Mary W. Ferris

997 total citations
21 papers, 742 citations indexed

About

Mary W. Ferris is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary W. Ferris has authored 21 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary W. Ferris's work include Hormonal Regulation and Hypertension (5 papers), Ubiquitin and proteasome pathways (4 papers) and Prostate Cancer Treatment and Research (3 papers). Mary W. Ferris is often cited by papers focused on Hormonal Regulation and Hypertension (5 papers), Ubiquitin and proteasome pathways (4 papers) and Prostate Cancer Treatment and Research (3 papers). Mary W. Ferris collaborates with scholars based in United States, Switzerland and Canada. Mary W. Ferris's co-authors include Peter C. Hollenhorst, Justin A. Budka, Mark F. Foecking, Celso E. Gómez-Sánchez, Elise P. Gómez-Sánchez, Barbara J. Graves, Joshua P. Plotnik, Heejoon Chae, Sun Kim and Leena Paul and has published in prestigious journals such as Nucleic Acids Research, Genes & Development and Molecular and Cellular Biology.

In The Last Decade

Mary W. Ferris

20 papers receiving 727 citations

Peers

Countries citing papers authored by Mary W. Ferris

Since Specialization

Citations

This map shows the geographic impact of Mary W. Ferris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary W. Ferris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary W. Ferris more than expected).

Fields of papers citing papers by Mary W. Ferris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary W. Ferris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary W. Ferris. The network helps show where Mary W. Ferris may publish in the future.

Co-authorship network of co-authors of Mary W. Ferris

This figure shows the co-authorship network connecting the top 25 collaborators of Mary W. Ferris. A scholar is included among the top collaborators of Mary W. Ferris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary W. Ferris. Mary W. Ferris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma 2018 ·Clinical Cancer Research ·Nur P. Damayanti, Justin A. Budka, Heba Khella, Mary W. Ferris, Sheng‐Yu Ku, Eric Kauffman, (unknown), (unknown), (unknown), Remi Adelaiye‐Ogala, May Elbanna, Ashley Orillion, Sreenivasulu Chintala, Chinghai Kao, W. Marston Linehan, George M. Yousef, Peter C. Hollenhorst, Роберто Пили	61
2	Common ELF1 deletion in prostate cancer bolsters oncogenic ETS function, inhibits senescence and promotes docetaxel resistance 2018 ·Genes & Cancer ·Justin A. Budka, Mary W. Ferris, (unknown), Peter C. Hollenhorst	17
3	ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2014 ·Nucleic Acids Research ·Joshua P. Plotnik, Justin A. Budka, Mary W. Ferris, Peter C. Hollenhorst	100
4	Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation 2014 ·Molecular Cancer ·(unknown), Justin A. Budka, Mary W. Ferris, Travis J. Jerde, Peter C. Hollenhorst	35
5	Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells 2011 ·Genes & Development ·Peter C. Hollenhorst, Mary W. Ferris, (unknown), Heejoon Chae, Sun Kim, Barbara J. Graves	118
6	The ETS Gene ETV4 Is Required for Anchorage-Independent Growth and a Cell Proliferation Gene Expression Program in PC3 Prostate Cells 2010 ·Genes & Cancer ·Peter C. Hollenhorst, Leena Paul, Mary W. Ferris, Barbara J. Graves	50
7	Global Effect of PEG-IFN- α and Ribavirin on Gene Expression in PBMC In Vitro 2004 ·Journal of Interferon & Cytokine Research ·Milton W. Taylor, W. M. Grosse, (unknown), (unknown), Xiaoning Wu, (unknown), Fred H. Smith, (unknown), Matthew J. Stephens, Mary W. Ferris, Jeanette N. McClintick, Ronald E. Jerome, Howard J. Edenberg	72
8	Induction of IL-1Ra in Resistant and Responsive Hepatitis C Patients Following Treatment with IFN-con1 2002 ·Journal of Interferon & Cytokine Research ·Scott J. Cotler, Teresa Craft, Mary W. Ferris, (unknown), Jonathan McCone, (unknown), Andrew Conrad, Donald M. Jensen, (unknown), Milton W. Taylor	9
9	An Analysis of Acute Changes in Interleukin-6 Levels After Treatment of Hepatitis C with Consensus Interferon 2001 ·Journal of Interferon & Cytokine Research ·Scott J. Cotler, K. Rajender Reddy, (unknown), (unknown), Anguo Liu, Teresa Craft, Mary W. Ferris, Andrew Conrad, (unknown), Mary Morrissey, Daniel Ganger, (unknown), Lawrence M. Blatt, Donald M. Jensen, Milton W. Taylor	24
10	Induction of Indoleamine 2,3-Dioxygenase In Vivo by IFN-con1 2001 ·Journal of Interferon & Cytokine Research ·Thayne L. Sweeten, Mary W. Ferris, Christopher J. McDougle, Paul Y. Kwo, Milton W. Taylor	9
11	An Indoleamine 2,3-Dioxygenase-Negative Mutant Is Defective in Stat1 DNA Binding: Differential Response to IFN-γ and IFN-α 2000 ·Journal of Interferon & Cytokine Research ·(unknown), (unknown), Mary W. Ferris, Milton W. Taylor	9
12	Women's voices : an oral history of women's health in Northern Ireland, 1900-90 1992 ·Mary W. Ferris	1
13	Rat mesenteric artery endothelial cells in culture secrete ET-1 1990 ·Life Sciences ·Celso E. Gómez-Sánchez, Mark F. Foecking, Mary W. Ferris, (unknown), Elise P. Gómez-Sánchez	9
14	Endothelin receptor subtypes and stimulation of aldosterone secretion. 1990 ·Hypertension ·Celso E. Gómez-Sánchez, Eduardo N. Cozza, Mark F. Foecking, Shirley Chiou, Mary W. Ferris	47
15	Synthesis of 18-hydroxycortisol and 18-oxocortisol in bovine adrenal slices 1989 ·Journal of Steroid Biochemistry ·(unknown), Mary W. Ferris, Mark F. Foecking, Elise P. Gómez-Sánchez	13
16	The production of monoclonal antibodies against aldosterone 1987 ·Steroids ·Celso E. Gómez-Sánchez, Mark F. Foecking, Mary W. Ferris, (unknown), (unknown), Elise P. Gómez-Sánchez	63
17	The production of a monoclonal antibody to 18-hydroxycortisol and other 18-hydroxylated steroids 1987 ·Steroids ·Celso E. Gómez-Sánchez, (unknown), Mary W. Ferris, Mark F. Foecking, Elise P. Gómez-Sánchez	7
18	Receptor Binding and Biological Activity of 18 Oxocortisol* 1985 ·Endocrinology ·Celso E. Gómez-Sánchez, Elise P. Gómez-Sánchez, J. S. C. Smith, Mary W. Ferris, Mark F. Foecking	43
19	Renal Receptor-Binding Activity of Reduced Metabolites of Aldosterone: Evidence for a Mineralocorticoid Effect outside of the Classic Aldosterone Receptor System* 1984 ·Endocrinology ·Celso E. Gómez-Sánchez, J. S. C. Smith, Mary W. Ferris, Elise P. Gómez-Sánchez	7
20	Receptor Binding and Biological Activity of 18-Hydroxycortisol* 1984 ·Endocrinology ·Elise P. Gómez-Sánchez, Celso E. Gómez-Sánchez, (unknown), Mary W. Ferris, Mark F. Foecking	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact